ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,089Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 617

$543K Total Retail Price of All Prescriptions

Rank: 71 out of 617

660 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 660 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,842 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 663 617 1 2
AMLODIPINE BESYLATE 661 612 2 6
WARFARIN SODIUM 521 497 3 7
LEVOTHYROXINE SODIUM 518 458 4 1
OMEPRAZOLE 451 394 5 3
FUROSEMIDE 450 414 6 4
LISINOPRIL 411 370 7 5
METOPROLOL SUCCINATE 367 352 8 12
METOPROLOL TARTRATE 348 341 9 11
METFORMIN HCL 330 300 10 9
ATENOLOL 278 267 11 17
HYDROCHLOROTHIAZIDE 254 238 12 13
POTASSIUM CHLORIDE 251 234 13 10
MIRTAZAPINE 223 223 14 50
HYDROCODONE-ACETAMINOPHEN 209 190 S3 15 8
ATORVASTATIN CALCIUM 203 189 16 14
LOSARTAN POTASSIUM 185 185 17 22
GABAPENTIN 182 161 18 16
ALENDRONATE SODIUM 179 163 19 25
ALLOPURINOL 177 168 20 27
PREDNISONE 157 152 21 31
MELOXICAM 148 132 22 24
TAMSULOSIN HCL 145 119 23 26
CITALOPRAM HBR 139 107 24 18
DOXAZOSIN MESYLATE 125 125 25 79
NAMENDA 118 107 26 35
BENAZEPRIL HCL 115 102 27 44
LOSARTAN-HYDROCHLOROTHIAZIDE 110 110 28 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 101 29 29
ZOLPIDEM TARTRATE 98 88 30 23
FLUTICASONE PROPIONATE 95 82 31 36
KLOR-CON M20 90 90 32 116
PRAVASTATIN SODIUM 87 67 33 21
DIGOXIN 86 80 34 48
ATENOLOL-CHLORTHALIDONE 85 85 35 142
DIOVAN 85 85 35 41
POLYETHYLENE GLYCOL 3350 81 73 37 32
DILTIAZEM ER 80 78 38 81
ADVAIR DISKUS 79 55 39 38
TRIAMTERENE-HYDROCHLOROTHIAZID 75 66 40 122
GLIMEPIRIDE 75 71 40 33
DONEPEZIL HCL 74 74 42 30
ENALAPRIL MALEATE 73 73 43 34
SERTRALINE HCL 71 62 44 20
RISPERIDONE 70 58 45 71
ISOSORBIDE MONONITRATE ER 66 66 46 52
TRAMADOL HCL 65 60 47 15
LANTUS 65 56 47 39
ROPINIROLE HCL 62 59 49 66
BUSPIRONE HCL 62 49 49 131
METOLAZONE 62 59 49 159
PROAIR HFA 62 53 49 75
CLONIDINE HCL 62 62 49 55
AZITHROMYCIN 59 53 54 70
CYMBALTA 58 42 55 49
CELEBREX 56 47 56 63
CRESTOR 55 51 57 28
TRIAMTERENE-HCTZ 55 52 57 47
METFORMIN HCL ER 54 54 59 72
KLOR-CON M10 53 53 60 158
CLOPIDOGREL 53 47 60 53
AMITRIPTYLINE HCL 52 36 R 62 56
CIPROFLOXACIN HCL 51 48 63 60
RANITIDINE HCL 51 51 63 40
FENTANYL 50 46 S2 65 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.